|
[1]
|
Global Report on Diabetes. WHO Website. http://www.who.int
|
|
[2]
|
中国2型糖尿病防治指南(2017年版) [J]. 中国实用内科杂志, 2018, 38(4): 292-344.
|
|
[3]
|
Li, Y., Teng, D., Shi, X., et al. (2020) Prevalence of Diabetes Recorded in Mainland China Using 2018 Diagnostic Criteria from the American Diabetes Association: National Cross Sectional Study. BMJ, 369, m997. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Cheng, H.T., Xu, X., Lim, P.S., et al. (2021) Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015. Diabetes Care, 44, 89-97. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Afkarian, M., Zelnick, L.R., Hall, Y.N., et al. (2016) Clinical Manifesta-tions of Kidney Disease among US Adults with Diabetes, 1988-2014. JAMA, 316, 602-610. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
de Boer, I.H., Rue, T.C., Hall, Y.N., et al. (2011) Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States. JAMA, 305, 2532-2539. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Zhang, X.X., Kong, J. and Yun, K. (2020) Prevalence of Diabetic Nephropathy among Patients with Type 2 Diabetes Mellitus in China: A Meta-Analysis of Observational Studies. Jour-nal of Diabetes Research, 2020, Article ID: 2315607. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Anders, H.J., Huber, T.B., Isermann, B., et al. (2018) CKD in Diabetes: Diabetic Kidney Disease versus Nondiabetic Kidney Disease. Nature Reviews Nephrology, 14, 361-377. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Zhang, L., Long, J., Jiang, W., et al. (2016) Trends in Chronic Kidney Disease in China. The New England Journal of Medicine, 375, 905-906. [Google Scholar] [CrossRef]
|
|
[10]
|
American Diabetes Association (2020) Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43, S135-S151. [Google Scholar] [CrossRef]
|
|
[11]
|
Vallon, V. and Thomson, S.C. (2020) The Tubular Hypothesis of Nephron Filtration and Diabetic Kidney Disease. Nature Reviews Nephrology, 16, 317-336. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Tervaert, T.W., Mooyaart, A.L., Amann, K., et al. (2010) Patho-logic Classification of Diabetic Nephropathy. Journal of the American Society of Nephrology, 21, 556-563. [Google Scholar] [CrossRef]
|
|
[13]
|
Mise, K., Hoshino, J., Ueno, T., et al. (2016) Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β- d-glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy. Clinical Journal of the American Society of Nephrology, 11, 593-601. [Google Scholar] [CrossRef]
|
|
[14]
|
Hoshino, J., Furuichi, K., Yamanouchi, M., et al. (2018) A New Pathological Scoring System by the Japanese Classification to Predict Renal Outcome in Diabetic Nephropathy. PLOS ONE, 13, e0190923. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Adler, A.I., Stevens, R.J., Manley, S.E., et al. (2003) Develop-ment and Progression of Nephropathy in Type 2 Diabetes: The United Kingdom Prospective Diabetes Study (UKPDS64). Kidney International, 63, 225-232. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wu, B., Zhang, S., Lin, H., et al. (2018) Prevention of Re-nal Failure in Chinese Patients with Newly Diagnosed Type 2 Diabetes: A Cost-Effectiveness Analysis. Journal of Dia-betes Investigation, 9, 152-161. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
韩志明, 谷欣. 血清结合珠蛋白对2型糖尿病患者肾功能预测价值分析[J]. 检验医学与临床, 2015(17): 2605-2607.
|
|
[18]
|
Andersen, C., Stodkilde, K., Saederup, K.L., et al. (2017) Haptoglo-bin. Antioxidants & Redox Signaling, 26, 814-831. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Conway, B., Fried, L. and Orchard, T. (2008) Hemoglobin and Overt Nephropathy Complications in Type 1 Diabetes. Annals of Epidemiology, 18, 147-155. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Goldenstein, H., Levy, N.S., Lipener, Y.T., et al. (2012) Haptoglobin Genotype and Its Role in Determining Heme-Iron Mediated Vascular Disease. Pharmacological Research, 66, 1-6. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Dahan, I., Thauho, N., Nakhoul, F., Nakhoul, N., Jabaly, H. and Farber, E. (2016) Haptoglobin Polymorphism as an Independent Predictor of Diabetic Nephropathy and Reti-nopathy. Harefuah, 155, 439-442.
|
|
[22]
|
Orchard, T.J., Sun, W., Cleary, P.A., et al. (2013) Haptoglobin Genotype and the Rate of Renal Function Decline in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Nterven-tions and Complications Study. Diabetes, 62, 3218-3223. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Orchard, T.J., Backlund, J.C., Costacou, T., et al. (2016) Haptoglobin 2-2 Genotype and the Risk of Coronary Artery Disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC). Journal of Diabetes and Its Complications, 30, 1577-1584. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Nakhoul, F., Nakhoul, N., Asleh, R., Miller-Lotan, R. and Levy, A.P. (2013) Is the Hp 2-2 Diabetic Mouse Model a Good Model to Study Diabetic Nephropathy? Diabetes Re-search and Clinical Practice, 100, 289-297. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
李宏杰, 要瑞莉, 武慧丽, 等. 触珠蛋白在家兔肠系膜上动脉闭塞性休克前后血清差异表达的研究[J]. 中国应用生理学杂志, 2012, 28(2): 143-144, 178.
|
|
[26]
|
王美娟, 侯俊秀. 尿结合珠蛋白肌酐比对糖尿病肾病的临床研究[J]. 内蒙古医科大学学报, 2018, 40(4): 344-348+357. [Google Scholar] [CrossRef]
|
|
[27]
|
Bhensdadia, N.M., Hunt, K.J., Lopes-Virella, M.F., et al. (2013) Urine Haptoglobin Levels Predict Early Renal Functional Decline in Patients with Type 2 Diabetes. Kidney International, 83, 1136-1143. [Google Scholar] [CrossRef] [PubMed]
|